시장보고서
상품코드
1986635

순차적 압박 장치 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Sequential Compression System Market Size, Share & Trends Analysis Report By Product (Compression Systems, Consumables & Accessories), By Technology (ASC, SSC), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ₩ 8,927,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ₩ 10,427,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ₩ 13,428,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

순차적 압박 장치 시장 요약

세계의 순차적 압박 장치 시장 규모는 2025년에 12억 7,000만 달러로 평가되었으며, 2033년까지 24억 7,000만 달러에 달할 것으로 예측되며, 2026년부터 2033년까지 CAGR 8.34%로 성장할 것으로 전망됩니다.

이 시장은 주로 정맥혈전색전증(VTE), 심부정맥혈전증(DVT) 및 기타 심혈관계 질환, 특히 고령자, 비만 및 수술 후 환자군에서 발생률이 증가함에 따라 주도되고 있습니다.

비침습적 기계적 예방법의 임상적 이점에 대한 인식이 높아진 데다 수술 전후 및 집중 치료 가이드라인에서 DVT 예방에 대한 강력한 권고가 나오면서 이 제품의 채택이 가속화되고 있습니다. 또한, 외래 수술 및 재택 치료로의 전환이 진행됨에 따라 휴대가 간편하고 사용하기 쉬운 연속압박장치에 대한 수요가 증가하고 있습니다. 경량 설계, 자동 압력 제어, 웨어러블 시스템 등 지속적인 기술 혁신은 환자의 순응도와 임상 결과를 더욱 향상시켜 시장의 지속적인 성장을 뒷받침하고 있습니다.

수술 건수의 증가는 이 산업의 주요 성장 요인입니다. 수술 건수가 증가하면 수술 후 정맥혈전색전증(VTE)의 위험과 예방적 개입의 필요성이 직접적으로 증가하기 때문입니다. 특히 정형외과 수술은 수술 시간이 길고 회복 기간 동안 이동성이 떨어지기 때문에 수요의 주요 견인차 역할을 하고 있습니다. 2025년 3월 미국 류마티스학회(ACR)의 보고에 따르면, 미국에서는 연간 약 79만 건의 무릎 인공관절 전치환술과 54만 4,000건의 고관절 전치환술이 시행되고 있으며, 이러한 수술에서 심부정맥혈전증(DVT)을 예방하기 위한 표준적인 기계적인 예방법으로 순차적 가압 시스템이 널리 권장되고 있습니다. 미국 질병예방통제센터(CDC)는 매년 미국에서 최대 90만 명이 정맥혈전색전증(VTE)을 앓고 있으며, 그 중 상당수가 입원이나 수술과 관련이 있는 것으로 추정하고 있습니다. 수술 건수가 지속적으로 증가함에 따라, 특히 고위험 정형외과 수술에서 순차적 압박 장치에 대한 수요는 꾸준히 증가할 것으로 예상되며, 이는 시장의 지속적인 성장을 뒷받침할 것으로 보입니다.

임상 가이드라인 및 예방 권고안은 고위험군 환자의 정맥혈전색전증(VTE)을 예방하기 위해 간헐적 공기압박(IPC) 장치와 같은 기계적 수단의 사용을 권장하는 근거에 기반한 진료 방침을 확립함으로써 순차적 압박 장치 시장을 견인하는 데 중요한 역할을 하고 있습니다. 혈액학 및 외과 학회의 주요 가이드라인에서는 VTE 위험이 높은 환자, 약물 예방에 대한 금기 사항(출혈 위험이 높은 환자 등)이 있는 환자에게 기계적 압박을 권장하고 있으며, 특히 정형외과 수술과 같은 대수술 후 심부정맥혈전증(DVT) 발생률을 낮추기 위해 수술 환자에서 특히 정형외과와 같은 수술 후 심부정맥혈전증(DVT)의 발생을 줄이기 위해 IPC 장치의 사용을 지지하고 있습니다. 항응고제가 적합하지 않은 경우, 예방 조치를 취하지 않는 것보다 기계적 예방이 종종 우선시되며, 많은 수술 전후 프로토콜에서 단계적 압박 스타킹보다 IPC 장치가 우선시되기 때문에 병원 및 급성기 의료 현장에서 임상의의 순차적 압박 장치에 대한 의존도가 더욱 높아지고 있습니다.

특히 고령자, 비만, 당뇨병 환자 또는 운동 기능이 제한적인 환자에서 하지정맥류 궤양(VLU) 발생률이 증가함에 따라 효과적인 혈액순환 촉진 요법에 대한 수요가 증가하고 있습니다. 순차적 압박 장치는 정맥 혈류를 개선하고, 부종을 줄이고, 상처 치유를 촉진하여 VLU 관리에 중요한 역할을 합니다. 특히, 정적 압박만으로는 충분하지 않거나 환자의 순응도가 낮은 경우에 그 효과가 발휘됩니다. 장기적인 상처 관리, 재택 치료 및 궤양 재발 예방에 대한 관심이 높아짐에 따라 고급 압박 시스템의 사용이 더욱 확대되어 시장 성장을 주도하고 있습니다.

자주 묻는 질문

  • 순차적 압박 장치 시장 규모는 어떻게 예측되나요?
  • 순차적 압박 장치의 주요 성장 요인은 무엇인가요?
  • 순차적 압박 장치의 임상적 이점은 무엇인가요?
  • 순차적 압박 장치의 기술 혁신은 어떤 영향을 미치고 있나요?
  • 고위험군 환자에게 권장되는 기계적 예방 방법은 무엇인가요?
  • 순차적 압박 장치의 사용이 증가하는 이유는 무엇인가요?

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 순차적 압박 장치 시장 : 변수, 동향, 범위

제4장 순차적 압박 장치 시장 : 제품별 추정·동향 분석

제5장 순차적 압박 장치 시장 : 기술별 추정·동향 분석

제6장 순차적 압박 장치 시장 : 용도별 추정·동향 분석

제7장 순차적 압박 장치 시장 : 최종 용도별 추정·동향 분석

제8장 순차적 압박 장치 시장 : 제품, 기술, 용도 및 최종 용도별 지역별 추정·동향 분석

제9장 경쟁 구도

KSM 26.04.28

Sequential Compression System Market Summary

The global sequential compression system market size was valued at USD 1.27 billion in 2025 and is projected to reach USD 2.47 billion by 2033, growing at a CAGR of 8.34% from 2026 to 2033. The industry is primarily driven by the rising incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), and other circulatory disorders, particularly among aging, obese, and post-surgical patient populations.

Increasing awareness of the clinical benefits of non-invasive mechanical prophylaxis, along with strong recommendations for DVT prevention in perioperative and critical-care guidelines, is accelerating adoption. In addition, the growing shift toward outpatient procedures and home-based care is boosting demand for portable, user-friendly sequential compression devices. Continuous technological advancements, such as lightweight designs, automated pressure control, and wearable systems, are further improving patient compliance and clinical outcomes, thereby supporting sustained market growth.

Growth in surgical procedures is a key driver of the industry, as higher surgical volumes directly increase the risk of postoperative venous thromboembolism (VTE) and the need for preventive interventions. Orthopedic surgeries, in particular, represent a major demand driver due to prolonged operative time and reduced mobility during recovery. According to the American College of Rheumatology in March 2025, approximately 790,000 total knee replacements and 544,000 total hip replacements are performed annually in the U.S., procedures for which sequential compression systems are widely recommended as standard mechanical prophylaxis to prevent deep vein thrombosis (DVT). This elevated risk is further highlighted by the U.S. Centers for Disease Control and Prevention (CDC), which estimates that up to 900,000 people in the U.S. are affected by VTE each year, with a significant proportion linked to hospitalization or surgery. As surgical volumes continue to rise, especially in high-risk orthopedic procedures, demand for sequential compression systems is expected to grow steadily, supporting sustained market expansion.

Clinical guidelines and prophylaxis recommendations play a significant role in driving the sequential compression system market by establishing evidence-based practices that encourage the use of mechanical methods, such as intermittent pneumatic compression (IPC) devices, to prevent venous thromboembolism (VTE) in high-risk patients. Leading guidelines from hematology and surgical societies recommend mechanical compression for patients who are at increased risk of VTE but have contraindications to pharmacological prophylaxis (such as high bleeding risk), and also support the use of IPC devices, often in combination with pharmacological agents, for surgical patients to reduce DVT incidence, particularly after major operations like orthopedic procedures. Mechanical prophylaxis is frequently preferred over no prophylaxis when anticoagulants are not suitable, and IPC devices are preferred over graduated compression stockings in many perioperative protocols, further strengthening clinicians' reliance on sequential compression systems in hospitals and acute care settings.

As the incidence of VLUs increases, particularly among the aging population, obese patients, and individuals with diabetes or limited mobility, demand for effective circulation-enhancing therapies is rising. Sequential compression systems play an important role in VLU management by improving venous blood flow, reducing edema, and supporting wound healing, especially when static compression alone is insufficient or patient adherence is low. The growing emphasis on long-term wound care, home-based treatment, and the prevention of ulcer recurrence is further expanding the use of advanced compression systems, thereby driving market growth.

Global Sequential Compression System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sequential compression system market report on the basis of product, application, technology, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Compression Systems
    • Stationary/Tabletop Units
    • Portable & Wearable Units
  • Consumables & Accessories
    • Compression Sleeves
    • Garments
    • Replacement Tubing & Connectors
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Alternate Sequential Compression (ASC)
  • Simultaneous Sequential Compression (SSC)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Deep Vein Thrombosis (DVT) Prevention
  • Lymphedema Management
  • Chronic Venous Insufficiency (CVI) & Ulcer Management
  • Sports Recovery & Performance
  • Others
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Institutional Settings
    • Hospitals
    • Specialty Clinics
    • Rehabilitation & Skilled Nursing Facilities
  • Home & Retail
    • Home Healthcare
    • Direct-to-Consumer (DTC) Sports/Fitness Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sequential Compression System Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), and chronic venous insufficiency
      • 3.2.1.2. Growing elderly and immobile patient population increasing demand for preventive compression therapy
      • 3.2.1.3. Increasing surgical volumes and longer postoperative recovery periods
      • 3.2.1.4. Technological advancements such as portable, wireless, and smart compression systems improving patient compliance
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced sequential compression systems and disposable garments
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing demand for home-based and wearable compression therapy devices
      • 3.2.3.2. Integration of digital health features, remote monitoring, and data-driven therapy optimization
      • 3.2.3.3. Increasing focus on early mobility and enhanced recovery after surgery (ERAS) protocols
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Ensuring patient adherence and correct device usage outside clinical settings
  • 3.3. Sequential Compression System Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Sequential Compression System Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Sequential Compression System Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Sequential Compression System Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Compression Systems
      • 4.3.1.1. Compression systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Stationary/tabletop units (clinical-grade)
        • 4.3.1.2.1. Stationary/tabletop units (clinical-grade) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Portable & wearable units (tubeless, battery-operated)
        • 4.3.1.3.1. Portable & wearable units (tubeless, battery-operated) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Consumables & Accessories
      • 4.3.2.1. Consumables & accessories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Compression sleeves
        • 4.3.2.2.1. Compression sleeves market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Garments
        • 4.3.2.3.1. Garments market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.4. Replacement tubing & connectors
        • 4.3.2.4.1. Replacement tubing & connectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Sequential Compression System Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Sequential Compression System Market: Technology Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Sequential Compression System Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
    • 5.3.1. Alternate Sequential Compression (ASC)
      • 5.3.1.1. Alternate sequential compression (ASC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Simultaneous Sequential Compression (SSC)
      • 5.3.2.1. Simultaneous sequential compression (SSC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Sequential Compression System Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Sequential Compression System Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global Sequential Compression System Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 6.3.1. Deep Vein Thrombosis (DVT) Prevention
      • 6.3.1.1. Deep vein thrombosis (DVT) prevention market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Lymphedema Management/CVI
      • 6.3.2.1. Lymphedema management/CVI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Chronic Venous Insufficiency (CVI) & Ulcer Management
      • 6.3.3.1. Chronic venous insufficiency (CVI) & ulcer management market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Sports Recovery & Performance
      • 6.3.4.1. Sports recovery & performance market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Others
      • 6.3.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Sequential Compression System Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Sequential Compression System Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Global Sequential Compression System Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Institutional Settings
      • 7.3.1.1. Institutional settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.1.2. Hospitals
        • 7.3.1.2.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.1.3. Specialty Clinics
        • 7.3.1.3.1. Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.1.4. Rehabilitation & Skilled Nursing Facilities (LTC)
        • 7.3.1.4.1. Rehabilitation & skilled nursing facilities (LTC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Home & Retail
      • 7.3.2.1. Home & retail market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.2.2. Home healthcare
        • 7.3.2.2.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.2.3. Direct-to-consumer (DTC) sports/fitness centers
        • 7.3.2.3.1. Direct-to-consumer (DTC) sports/fitness centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Sequential Compression System Market: Regional Estimates & Trend Analysis by Product, Technology, Application, and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Denmark sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Competitive scenario
      • 8.4.9.3. Regulatory framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. China sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Japan sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Argentina sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive scenario
      • 8.7.5.3. Regulatory framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait sequential compression system market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
    • 9.5.6. Company Profiles
    • 9.5.7. Cardinal Health
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Arjo
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Tactile Medical
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Bio Compression Systems
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Mego Afek
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Enovis
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Zimmer Biomet
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. AIROS Medical
      • 9.5.14.1. Company overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Hyperice
      • 9.5.15.1. Company overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product Benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. Therabody
      • 9.5.16.1. Company overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product Benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. BREG, Inc.
      • 9.5.17.1. Company overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product Benchmarking
      • 9.5.17.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제